modafinil and memantine

modafinil has been researched along with memantine in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Franke, AG; Huss, M; Konrad, A; Lieb, K1
Brown, PD; Day, J; Gehring, K; Grant, R; Grosshans, D; Li, J; Taphoorn, M; Zienius, K1
Buoli, M; Cahn, W; Serati, M1
Daulatzai, MA1
Connemann, BJ; Gahr, M; Schönfeldt-Lecuona, C; Zeiss, R1
Brown, PD; Day, J; Gehring, K; Grosshans, D; Kirkman, MA; Li, J; Taphoorn, M; Zienius, K1

Reviews

6 review(s) available for modafinil and memantine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Stimulant and non-stimulant medication in current and future therapy for ADHD].
    Fortschritte der Neurologie-Psychiatrie, 2012, Volume: 80, Issue:3

    Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Dextroamphetamine; Fatty Acids, Omega-3; Guanfacine; Histamine Agonists; Humans; Isoxazoles; Lisdexamfetamine Dimesylate; Memantine; Methylphenidate; Modafinil; Off-Label Use; Propylamines; Pyridines; Pyrrolidines; Receptors, AMPA

2012
Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation.
    The Cochrane database of systematic reviews, 2014, Dec-18, Issue:12

    Topics: Adult; Benzhydryl Compounds; Cognition Disorders; Cranial Irradiation; Donepezil; Humans; Indans; Memantine; Methylphenidate; Modafinil; Nootropic Agents; Piperidines; Randomized Controlled Trials as Topic

2014
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
    Expert review of neurotherapeutics, 2016, Volume: 16, Issue:2

    Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents

2016
Pharmacotherpy and Alzheimer's Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach.
    Current pharmaceutical design, 2016, Volume: 22, Issue:16

    Topics: Alzheimer Disease; Animals; Benzhydryl Compounds; Cognitive Dysfunction; Humans; Melatonin; Memantine; Minocycline; Modafinil

2016
Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation.
    The Cochrane database of systematic reviews, 2022, 11-25, Volume: 11

    Topics: Adult; Brain Neoplasms; Cognition; Cognitive Dysfunction; Cranial Irradiation; Dementia; Donepezil; Fatigue; Humans; Memantine; Methylphenidate; Modafinil; Quality of Life

2022

Other Studies

2 other study(ies) available for modafinil and memantine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Sensitivity of Quantitative Signal Detection in Regards to Pharmacological Neuroenhancement.
    International journal of molecular sciences, 2017, Jan-05, Volume: 18, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adverse Drug Reaction Reporting Systems; Atomoxetine Hydrochloride; Australia; Benzhydryl Compounds; Canada; Central Nervous System Stimulants; Drug-Related Side Effects and Adverse Reactions; Excitatory Amino Acid Antagonists; France; Germany; Humans; Italy; Memantine; Methylphenidate; Modafinil; Pharmacovigilance; Spain; Substance-Related Disorders; United Kingdom; United States; Wakefulness-Promoting Agents

2017